11/21/24 12:04 | 11/20/24 | AIM | Aim Immunotech Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K | FL | DO | CEO,P | P | 17 | 0.1990 | 0 | 85 | 5 | 1,638 | D | | | | | | | | | | | | | | |
11/20/24 12:46 | 11/20/24 | AIM | Aim Immunotech Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K | FL | DO | CEO,P | P | 11 | 0.1830 | 0 | 60 | 4 | 1,553 | D | | | | | | | | | | | | | | |
9/17/24 12:05 | 9/16/24 | AIM | Aim Immunotech Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K | FL | DO | CEO,P | P | 2 | 0.3030 | 0 | 5 | 0 | 1,493 | D | | | | | | | | | | | | | | |
9/16/24 15:45 | 9/13/24 | AIM | Aim Immunotech Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K | FL | DO | CEO,P | P | 6 | 0.3080 | 0 | 20 | 1 | 1,488 | D | | | | | | | | | | | | | | |
5/7/24 08:30 | 5/6/24 | AIM | Aim Immunotech Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K | FL | DO | CEO,P | P | 25 | 0.4050 | 0 | 62 | 9 | 778 | D | | | | | | | | | | | | | | |
3/18/24 15:01 | 3/15/24 | AIM | Aim Immunotech Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K | FL | DO | CEO,P | P | 25 | 0.3300 | 0 | 76 | 12 | 716 | D | | | | | | | | | | | | | | |
11/27/23 12:56 | 11/27/23 | AIM | Aim Immunotech Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K | FL | DO | CEO,P | P | 15 | 0.4430 | 0 | 34 | 6 | 641 | D | | | | | | | | | | | | | | |
9/29/23 15:29 | 9/29/23 | AIM | Aim Immunotech Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K | FL | DO | CEO,P | P | 10 | 0.4410 | 0 | 23 | 4 | 607 | D | | | | | | | | | | | | | | |
8/25/23 14:26 | 8/25/23 | AIM | Aim Immunotech Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K | FL | DO | CEO,P | P | 6 | 0.6690 | 0 | 8 | 1 | 584 | D | | | | | | | | | | | | | | |
8/24/23 13:52 | 8/24/23 | AIM | Aim Immunotech Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K | FL | DO | CEO,P | P | 10 | 0.6670 | 0 | 15 | 3 | 576 | D | | | | | | | | | | | | | | |
7/17/23 19:20 | 7/17/23 | AIM | Aim Immunotech Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K | FL | DO | CEO,P | P | 10 | 0.5900 | 0 | 17 | 3 | 561 | D | | | | | | | | | | | | | | |
1/4/23 07:30 | 1/3/23 | AIM | Aim Immunotech Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K | FL | DO | CEO,P | P | 50 | 0.3100 | 0 | 161 | 42 | 544 | D | | | | | | | | | | | | | | |
7/16/21 12:07 | 7/16/21 | AIM | Aim Immunotech Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | CEO,P | P | 30 | 1.92 | 0 | 16 | 7 | 225 | D | | | | | | | | | | | | | | |
2/24/21 12:03 | 2/24/21 | AIM | Aim Immunotech Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | CEO,P | P | 25 | 2.26 | 0 | 11 | 6 | 210 | D | | | | | | | | | | | | | | |
12/17/20 12:22 | 12/17/20 | AIM | Aim Immunotech Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | CEO | P | 25 | 1.72 | 0 | 15 | 8 | 199 | D | | | | | | | | | | | | | | |
9/3/20 10:53 | 9/3/20 | AIM | Aim Immunotech Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | CEO,P | P | 25 | 2.03 | 0 | 12 | 7 | 184 | D | | | | | | | | | | | | | | |
8/21/20 08:08 | 8/21/20 | AIM | Aim Immunotech Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | CEO | P | 25 | 2.33 | 0 | 11 | 7 | 172 | D | | | | | | | | | | | | | | |
6/27/19 15:32 | 6/27/19 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | Exec. Vi | P | 12 | 4.37 | 0 | 3 | 4 | 63 | D | | | | | | | | | | | | | | |
6/25/19 12:17 | 6/21/19 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | Exec. Vi | P.a | 118 | 4.03 | 0 | 29 | 95 | 60 | D | | | | | | | | | | | | | | |
6/21/19 11:11 | 6/21/19 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | Exec. Vi | P | 118 | 4.03 | 0 | 29 | 2 | 1,394 | D | | | | | | | | | | | | | | |
3/19/19 16:01 | 3/19/19 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | Exec. Vi | P | 2 | 0.1755 | 0 | 13 | 2 | 812 | D | | | | | | | | | | | | | | |
12/3/18 11:32 | 11/30/18 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | Exec. Vi | P | 4 | 0.1923 | 0 | 20 | 3 | 798 | D | | | | | | | | | | | | | | |
10/29/18 09:14 | 10/26/18 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | Exec. Vi | P | 1 | 0.2030 | 0 | 4 | 0 | 776 | D | | | | | | | | | | | | | | |
10/25/18 09:22 | 10/25/18 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | Exec. Vi | P | 20 | 0.2000 | 0 | 100 | 15 | 772 | D | | | | | | | | | | | | | | |
7/27/18 09:31 | 7/27/18 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | Exec. Vi | P | 10 | 0.2900 | 0 | 34 | 5 | 672 | D | | | | | | | | | | | | | | |
7/23/18 10:49 | 7/23/18 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | Exec. Vi | P | 35 | 0.3100 | 0 | 113 | 22 | 638 | D | | | | | | | | | | | | | | |
4/30/18 06:22 | 4/27/18 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | CEO,P | P | 10 | 0.3200 | 0 | 32 | 6 | 525 | D | | | | | | | | | | | | | | |
4/27/17 09:27 | 4/27/17 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | CEO,P | P | 50 | 0.6900 | 0 | 72 | 17 | 493 | D | -75 | -62 | -31 | 0 | 33 | 30 | 19 | 19 | -3 | -1 | | | | |
4/11/17 09:54 | 4/11/17 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | CEO,P | P | 100 | 0.5000 | 0 | 200 | 91 | 420 | D | -81 | -66 | -54 | -29 | 10 | -4 | 0 | 0 | 6 | 8 | 19 | | | |
12/23/16 12:31 | 12/22/16 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | CEO,P | P | 50 | 0.7300 | 0 | 68 | 45 | 220 | D | -76 | -28 | -52 | -44 | -23 | -14 | -18 | -7 | 10 | 0 | 0 | -20 | | |
11/1/16 13:27 | 11/1/16 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | CEO,P | P | 10 | 1.00 | 0 | 10 | 7 | 152 | D | -72 | -37 | -42 | -42 | -26 | -16 | -8 | -9 | -6 | -9 | -16 | -35 | -31 | |
7/8/16 17:10 | 7/8/16 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | CEO,P | P | 6 | 0.1184 | 0 | 48 | 3 | 1,704 | D | -60 | -37 | 50 | -8 | 0 | 9 | 0 | 0 | 0 | 0 | 58 | -17 | -47 | |
7/1/16 16:17 | 6/29/16 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | CEO,P | P.m | 20 | 0.1194 | 0 | 171 | 12 | 1,656 | D | -63 | -40 | 50 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 8 | -13 | -52 | |
3/21/16 09:33 | 3/18/16 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | CEO,P,Ex | P | 4 | 0.1322 | 0 | 30 | 2 | 1,485 | D | -68 | -43 | -28 | 30 | 0 | -7 | -19 | -19 | 15 | -8 | 8 | -15 | -5 | -65 |
3/14/16 11:16 | 3/11/16 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | CEO,P,Ex | P.a | 6 | 0.1578 | 0 | 40 | 3 | 1,455 | D | -62 | -30 | -6 | 45 | 78 | -6 | 0 | 7 | 0 | -19 | -19 | -25 | -28 | -72 |
3/14/16 10:47 | 3/10/16 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | CEO,P,Ex | P.a | 5 | 0.1630 | 0 | 30 | 2 | 1,415 | D | -62 | -30 | -6 | 45 | 78 | -6 | 0 | 7 | 0 | -19 | -19 | -25 | -28 | -72 |
3/14/16 08:17 | 3/11/16 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | CEO,P,Ex | P | 6 | 0.1578 | 0 | 40 | | 10 | D | -62 | -30 | -6 | 45 | 78 | -6 | 0 | 7 | 0 | -19 | -19 | -25 | -28 | -72 |
3/10/16 15:57 | 3/10/16 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | CEO,P,Ex | P | 5 | 0.1630 | 0 | 30 | New | 30 | D | -62 | -33 | -6 | 45 | 78 | 23 | 14 | 7 | 0 | 0 | -19 | -19 | -29 | -71 |
8/14/15 10:59 | 8/13/15 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | CFO,P,Se | P.m | 14 | 0.1800 | 0 | 79 | 6 | 1,385 | D | -25 | -36 | -25 | -28 | -10 | -5 | 0 | -5 | 0 | 0 | 0 | -22 | -33 | 0 |
4/28/15 10:00 | 4/27/15 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | CFO,Vice | P | 24 | 0.2443 | 0 | 100 | 8 | 1,305 | D | 0 | -32 | -23 | 0 | 0 | 5 | 0 | -8 | 9 | 13 | 0 | -13 | -39 | -35 |
4/21/15 10:00 | 4/20/15 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | CFO,Vice | P | 24 | 0.2391 | 0 | 100 | 9 | 1,205 | D | 9 | -25 | -25 | 0 | -4 | 4 | 9 | 4 | 0 | -4 | -4 | -17 | -38 | -42 |
4/15/15 12:23 | 4/15/15 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Equels Thomas K. | FL | DO | CFO,Vice | P | 23 | 0.2254 | 0 | 100 | 10 | 1,105 | D | -4 | -39 | -35 | -8 | -12 | -8 | -4 | 0 | 5 | 9 | 18 | -9 | -27 | -36 |